These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

362 related items for PubMed ID: 22674493

  • 1. Sustained therapeutic effects of percutaneous tibial nerve stimulation: 24-month results of the STEP study.
    Peters KM, Carrico DJ, MacDiarmid SA, Wooldridge LS, Khan AU, McCoy CE, Franco N, Bennett JB.
    Neurourol Urodyn; 2013 Jan; 32(1):24-9. PubMed ID: 22674493
    [Abstract] [Full Text] [Related]

  • 2. Percutaneous tibial nerve stimulation for the long-term treatment of overactive bladder: 3-year results of the STEP study.
    Peters KM, Carrico DJ, Wooldridge LS, Miller CJ, MacDiarmid SA.
    J Urol; 2013 Jun; 189(6):2194-201. PubMed ID: 23219541
    [Abstract] [Full Text] [Related]

  • 3. Long term sustained therapeutic effects of percutaneous posterior tibial nerve stimulation treatment of neurogenic overactive bladder in multiple sclerosis patients: 12-months results.
    Canbaz Kabay S, Kabay S, Mestan E, Cetiner M, Ayas S, Sevim M, Ozden H, Karaman HO.
    Neurourol Urodyn; 2017 Jan; 36(1):104-110. PubMed ID: 26352904
    [Abstract] [Full Text] [Related]

  • 4. A single-blind, randomized controlled trial to evaluate the effectiveness of transcutaneous tibial nerve stimulation (TTNS) in Overactive Bladder symptoms in women responders to percutaneous tibial nerve stimulation (PTNS).
    Martin-Garcia M, Crampton J.
    Physiotherapy; 2019 Dec; 105(4):469-475. PubMed ID: 30862384
    [Abstract] [Full Text] [Related]

  • 5. Randomized trial of percutaneous tibial nerve stimulation versus extended-release tolterodine: results from the overactive bladder innovative therapy trial.
    Peters KM, Macdiarmid SA, Wooldridge LS, Leong FC, Shobeiri SA, Rovner ES, Siegel SW, Tate SB, Jarnagin BK, Rosenblatt PL, Feagins BA.
    J Urol; 2009 Sep; 182(3):1055-61. PubMed ID: 19616802
    [Abstract] [Full Text] [Related]

  • 6. Long-term durability of percutaneous tibial nerve stimulation for the treatment of overactive bladder.
    MacDiarmid SA, Peters KM, Shobeiri SA, Wooldridge LS, Rovner ES, Leong FC, Siegel SW, Tate SB, Feagins BA.
    J Urol; 2010 Jan; 183(1):234-40. PubMed ID: 19913821
    [Abstract] [Full Text] [Related]

  • 7. A novel leadless, miniature implantable Tibial Nerve Neuromodulation System for the management of overactive bladder complaints.
    Heesakkers JPFA, Digesu GA, van Breda J, Van Kerrebroeck P, Elneil S.
    Neurourol Urodyn; 2018 Mar; 37(3):1060-1067. PubMed ID: 28892221
    [Abstract] [Full Text] [Related]

  • 8. Percutaneous tibial nerve stimulation in the treatment of refractory overactive bladder syndrome: is maintenance treatment necessary?
    van der Pal F, van Balken MR, Heesakkers JP, Debruyne FM, Bemelmans BL.
    BJU Int; 2006 Mar; 97(3):547-50. PubMed ID: 16469023
    [Abstract] [Full Text] [Related]

  • 9. Sacral nerve stimulation for voiding dysfunction: One institution's 11-year experience.
    Sutherland SE, Lavers A, Carlson A, Holtz C, Kesha J, Siegel SW.
    Neurourol Urodyn; 2007 Mar; 26(1):19-28; discussion 36. PubMed ID: 17078071
    [Abstract] [Full Text] [Related]

  • 10. Comparison of the effects of electrical stimulation and posterior tibial nerve stimulation in the treatment of overactive bladder syndrome.
    Gungor Ugurlucan F, Onal M, Aslan E, Ayyildiz Erkan H, Kizilkaya Beji N, Yalcin O.
    Gynecol Obstet Invest; 2013 Mar; 75(1):46-52. PubMed ID: 23171636
    [Abstract] [Full Text] [Related]

  • 11. Percutaneous tibial nerve stimulation for the treatment of urinary frequency, urinary urgency, and urge incontinence: results from a community-based clinic.
    Wooldridge LS.
    Urol Nurs; 2009 Mar; 29(3):177-85. PubMed ID: 19579411
    [Abstract] [Full Text] [Related]

  • 12. Neuromodulative treatment with percutaneous tibial nerve stimulation for intractable detrusor instability: outcomes following a shortened 6-week protocol.
    Yoong W, Ridout AE, Damodaram M, Dadswell R.
    BJU Int; 2010 Dec; 106(11):1673-6. PubMed ID: 20590544
    [Abstract] [Full Text] [Related]

  • 13. Transcutaneous posterior tibial nerve stimulation versus extended release oxybutynin in overactive bladder patients. A prospective randomized trial.
    Manríquez V, Guzmán R, Naser M, Aguilera A, Narvaez S, Castro A, Swift S, Digesu GA.
    Eur J Obstet Gynecol Reprod Biol; 2016 Jan; 196():6-10. PubMed ID: 26645117
    [Abstract] [Full Text] [Related]

  • 14. Symptom bother and health-related quality of life outcomes following solifenacin treatment for overactive bladder: the VESIcare Open-Label Trial (VOLT).
    Garely AD, Kaufman JM, Sand PK, Smith N, Andoh M.
    Clin Ther; 2006 Nov; 28(11):1935-46. PubMed ID: 17213014
    [Abstract] [Full Text] [Related]

  • 15. Posterior tibial nerve stimulation vs parasacral transcutaneous neuromodulation for overactive bladder in children.
    Barroso U, Viterbo W, Bittencourt J, Farias T, Lordêlo P.
    J Urol; 2013 Aug; 190(2):673-7. PubMed ID: 23422257
    [Abstract] [Full Text] [Related]

  • 16. Comparison of fesoterodine and tolterodine extended release for the treatment of overactive bladder: a head-to-head placebo-controlled trial.
    Herschorn S, Swift S, Guan Z, Carlsson M, Morrow JD, Brodsky M, Gong J.
    BJU Int; 2010 Jan; 105(1):58-66. PubMed ID: 20132103
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and tolerability of fesoterodine versus tolterodine in older and younger subjects with overactive bladder: a post hoc, pooled analysis from two placebo-controlled trials.
    DuBeau CE, Morrow JD, Kraus SR, Creanga D, Bavendam T.
    Neurourol Urodyn; 2012 Nov; 31(8):1258-65. PubMed ID: 22907761
    [Abstract] [Full Text] [Related]

  • 18. Percutaneous tibial nerve stimulation versus sham efficacy in the treatment of refractory overactive bladder: outcomes following a shortened 6-week protocol, a prospective randomized controlled trial.
    Lashin AM, Eltabey NA, Wadie BS.
    Int Urol Nephrol; 2021 Dec; 53(12):2459-2467. PubMed ID: 34601705
    [Abstract] [Full Text] [Related]

  • 19. Percutaneous tibial nerve stimulation versus tolterodine for overactive bladder in women: a randomised controlled trial.
    Preyer O, Umek W, Laml T, Bjelic-Radisic V, Gabriel B, Mittlboeck M, Hanzal E.
    Eur J Obstet Gynecol Reprod Biol; 2015 Aug; 191():51-6. PubMed ID: 26073262
    [Abstract] [Full Text] [Related]

  • 20. Randomized trial of percutaneous tibial nerve stimulation versus Sham efficacy in the treatment of overactive bladder syndrome: results from the SUmiT trial.
    Peters KM, Carrico DJ, Perez-Marrero RA, Khan AU, Wooldridge LS, Davis GL, Macdiarmid SA.
    J Urol; 2010 Apr; 183(4):1438-43. PubMed ID: 20171677
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.